## RJF: Raymond James Financial, Inc. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_10 0.1% below STRENGTH zone (3.0-6.0%); PEG 1.19 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($159.36)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. What Raymond James Financial (RJF)'s Record Client Asset Levels and Insider Selling Activity Mean For Shareholders**
- Source: Simply Wall Street | 20251222T150858 | Somewhat-Bullish | Relevance: 100%
- Raymond James Financial recently reported record client assets under administration of US$1.77 trillion, a 10% increase year over year, driven by strong advisor recruitment and favorable equity markets. Despite this growth, investment banking revenues saw a slight dip and insider share sales increased. Analysts from TD Cowen and Bank of America Securities have reiterated "Hold" ratings for RJF.

**2. Texas Permanent School Fund Corp Sells 7,063 Shares of Raymond James Financial, Inc. $RJF**
- Source: MarketBeat | 20251222T100839 | Neutral | Relevance: 100%
- Texas Permanent School Fund Corp significantly reduced its stake in Raymond James Financial by 35.6% in Q2, selling 7,063 shares. Additionally, insider Paul C. Reilly sold a substantial amount of shares, decreasing his position by over 33%. Despite these sales, Raymond James Financial reported strong quarterly earnings, beating estimates and increasing its dividend, with analysts maintaining a "Hold" rating with a target price of $180.45.

**3. Raymond James Financial (NYSE:RJF) Price Target Raised to $187.00 at Morgan Stanley**
- Source: MarketBeat | 20251222T174228 | Somewhat-Bullish | Relevance: 100%
- Morgan Stanley increased its price target for Raymond James Financial (NYSE:RJF) to $187.00 from $185.00, maintaining an "equal weight" rating, suggesting a potential 13.05% upside. This follows Raymond James' strong performance, beating quarterly earnings and revenue estimates. The financial services provider currently holds a consensus "Hold" rating from analysts with an average target price of $180.73.

**4. Morgan Stanley Adjusts PT on Raymond James Financial to $187 From $185, Keeps Equalweight Rating**
- Source: marketscreener.com | 20251222T111709 | Somewhat-Bullish | Relevance: 100%
- Morgan Stanley has updated its price target for Raymond James Financial, increasing it to $187 from $185. The firm has maintained its "Equalweight" rating on the financial services company. This adjustment reflects Morgan Stanley's current outlook on Raymond James Financial's performance.

**5. Congress Asset Management Co. Sells 101,863 Shares of Raymond James Financial, Inc. $RJF**
- Source: MarketBeat | 20251221T093244 | Somewhat-Bullish | Relevance: 100%
- Congress Asset Management Co. reduced its stake in Raymond James Financial by 13.7% in Q3, selling over 101,000 shares. Insider Paul C. Reilly also sold 130,687 shares, decreasing his holdings by 33.4%. Despite these sales, Raymond James Financial exceeded Q3 earnings expectations, raised its dividend, and maintains an average analyst price target of $180.45.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-22 | Morgan Stanley | $187 | $185 | +1% |
| 2025-12-10 | B of A Securiti | $196 | $194 | +1% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-22 | Morgan Stanley | main | Equal-Weight |
| 2025-12-10 | B of A Securiti | main | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 31 ($0.00M) |
| Sells | 18 ($0.53M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 46.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 1 / 9 |

**Top Holders:**
- Vanguard Group Inc: 11.1% (-1.4%)
- Blackrock Inc.: 7.4% (-2.9%)
- JPMORGAN CHASE & CO: 5.9% (+108.2%)
- Primecap Management : 4.9% (-3.7%)
- Wellington Managemen: 4.6% (-5.8%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.19 suggests fair value with growth premium. Forward P/E 12.3x attractive for 12% earnings growth. Quality metrics strong (margin 15%). Institutional flow bullish (1 buying vs 9 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $33.1B |
| Beta | 1.01 |
| 52W Range | $117.57 - $177.66 |
| Short Interest | 4.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.19 |
| Forward P/E | 12.3 |
| Current P/E | 13.8 |
| YoY Growth | 12.4% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 1.3% to 0.1% (-1.2% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 2.9pp (needs >3.0% for momentum thesis). MRS_5 at 0.0% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 60. OFD pattern: -SLN (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 0.06% (CS: 71) | Neutral |
| RSI_14 | 59.9 | Neutral |
| MACD Histogram | 0.42 | Bullish |
| vs SMA20 | 1.027x | Above |
| vs SMA50 | 1.032x | Above |
| vs SMA200 | 1.065x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $165.76
- **Stop Loss:** $159.36 (3.9% risk)
- **Target:** $172.16 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 140
- **Position Value:** $23,206.40
- **Portfolio %:** 23.21%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with moderate risk appetite in holiday-thinned conditions. VIX at 52-week lows suggests complacency, but modest breadth improvement and stable yields indicate underlying stability. Focus on quality positioning ahead of 2026 catalysts.*

### Earnings

**Next:** 2026-01-28 (Est: $2.93)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.83 | $3.11 | +10.0% |
| 2025Q2 | $2.36 | $2.18 | -7.5% |
| 2025Q1 | $2.44 | $2.42 | -0.7% |
| 2024Q4 | $2.69 | $2.93 | +8.8% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*